TP53 and breast cancer: As a tumor suppressor, tRF3E competes with the over-expressed RNA binding protein nucleolin (NCL) in BC to cause the release of p53 mRNA, which in turn promotes the translation of p53, thereby inhibiting the proliferation of cancer cells95.